Loading
Latest filing published 17 May 2018 for Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.).
No signal scores available.
Mary-Jane Eleanor Burkett appears in our data through filings on Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) shares, published by SEDI. Over a trading history stretching from 12 September 2016 to 16 May 2018, the count stands at 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 17 May 2018, the filings show a transaction in Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.). Typically, a trade is published a median of 1 day after it takes place. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations